We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UDR icon
651
UDR
UDR
$12.9B
$22.9M 0.02%
676,506
-2,403
-0.4% -$88.2K
HALO icon
652
Halozyme
HALO
$9.72B
$22.8M 0.02%
353,181
+7,385
+2% +$521K
LFUS icon
653
Littelfuse
LFUS
$10.2B
$22.8M 0.02%
67,050
+1,416
+2% +$460K
FLR icon
654
Fluor
FLR
$7.29B
$22.6M 0.02%
485,408
-13,357
-3% -$622K
CAVA icon
655
CAVA Group
CAVA
$7.22B
$22.6M 0.02%
279,568
+6,061
+2% +$442K
HLI icon
656
Houlihan Lokey
HLI
$9.68B
$22.5M 0.02%
156,848
-495
-0.3% -$81.4K
DOC icon
657
Healthpeak Properties
DOC
$15.4B
$22.5M 0.02%
1,366,788
-23,799
-2% -$408K
ZBRA icon
658
Zebra Technologies
ZBRA
$12.4B
$22.4M 0.02%
107,289
+8,048
+8% +$1.89M
EMN icon
659
Eastman Chemical
EMN
$7.8B
$22.4M 0.02%
293,768
+5,743
+2% +$414K
SITM icon
660
SiTime
SITM
$16.6B
$22.4M 0.02%
64,723
+8,750
+16% +$3.22M
R icon
661
Ryder
R
$10.3B
$22.2M 0.02%
108,588
-3,590
-3% -$726K
UHS icon
662
Universal Health Services
UHS
$9.43B
$22.2M 0.02%
124,084
+1,915
+2% +$393K
CGNX icon
663
Cognex
CGNX
$10.3B
$22.2M 0.02%
452,345
+5,274
+1% +$246K
JXN icon
664
Jackson Financial
JXN
$8.32B
$22.1M 0.02%
209,167
+5,402
+3% +$604K
NNN icon
665
NNN REIT
NNN
$9.39B
$22.1M 0.02%
525,464
+2,972
+0.6% +$128K
CRDO icon
666
Credo Technology Group
CRDO
$39.7B
$22M 0.02%
234,858
+11,380
+5% +$1.39M
RPRX icon
667
Royalty Pharma
RPRX
$26.1B
$22M 0.02%
459,298
-6,049
-1% -$265K
ALGN icon
668
Align Technology
ALGN
$12B
$22M 0.02%
128,481
+3,776
+3% +$661K
GEN icon
669
Gen Digital
GEN
$15.6B
$22M 0.02%
1,168,383
-6,204
-0.5% -$144K
CFR icon
670
Cullen/Frost Bankers
CFR
$10.3B
$22M 0.02%
160,430
+1,519
+1% +$210K
AYI icon
671
Acuity Brands
AYI
$9.88B
$22M 0.02%
78,475
+2,720
+4% +$826K
CHRD icon
672
Chord Energy
CHRD
$7.79B
$22M 0.02%
154,433
+2,775
+2% +$303K
IJH icon
673
iShares Core S&P Mid-Cap ETF
IJH
$123B
$21.9M 0.02%
324,768
+141,687
+77% +$9.83M
ASTS icon
674
AST SpaceMobile
ASTS
$16.8B
$21.9M 0.02%
263,856
+36,420
+16% +$3.44M
SFM icon
675
Sprouts Farmers Market
SFM
$7.04B
$21.7M 0.02%
281,403
+11,465
+4% +$856K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.